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Lymphadenopathy is a common radiological finding in many thoracic diseases and may be caused by a
variety of infectious, inflammatory, and neoplastic conditions. This review aims to describe the patterns
of mediastinal and hilar lymphadenopathy found in benign diseases in immunocompetent patients.
Computed tomography is the method of choice for the evaluation of lymphadenopathy, as it is able to
demonstrate increased size of individual nodes, abnormalities of the interface between the mediastinum
and lung, invasion of surrounding fat, coalescence of adjacent nodes, obliteration of the mediastinal fat,
and hypo- and hyperdensity in lymph nodes. Intravenous contrast enhancement may be needed to help
distinguish nodes from vessels. The most frequent infections resulting in this finding are tuberculosis andCentro, CEP 90030041, Porto Alegre, Rio Grande do Sul, Brazil.
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Benign disease
Computed tomographyfungal disease (particularly histoplasmosis and coccidioidomycosis). Sarcoidosis is a relatively frequent
cause of lymphadenopathy in young adults, and can be distinguished from other diseases e especially
when enlarged lymph nodes are found to be multiple and symmetrical. Other conditions discussed in
this review are silicosis, drug reactions, amyloidosis, heart failure, Castleman's disease, viral infections,
and chronic obstructive pulmonary disease.
© 2016 Elsevier Ltd. All rights reserved.Contents
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Lymphadenopathy refers to the abnormality of lymph node size,
density, and/or number [1]. Computed tomography (CT) is the
method of choice for the evaluation of these features. CT findings in
thoracic lymphadenopathy include loss of normal ovoid shape,
increased size of individual nodes, focal contour abnormalities,
hypo- or hyperdensity in lymph nodes, invasion of surrounding
mediastinal fat, coalescence of adjacent and enlarged nodes, and
diffuse soft-tissue attenuation through the mediastinum, obliter-
ating the mediastinal fat [2,3].
Frequent causes of lymphadenopathy are inflammatory and
neoplastic conditions, as well as several infections. Thus, numerous
features should be considered when assessing nodal disease to
distinguish benign from malignant nodes [1]. A normal node tends
to have a uniform appearance. The presence of fat often (but not
invariably) indicates benignity. Malignant nodes, on the other hand,
exhibit irregular borders and tend to bemore round than elongated
[4]. Heterogeneous enhancement of an enlarged node is also likely
to represent malignancy, although this feature may be seen in
benign diseases, such as tuberculosis (TB) [5,6].
Regarding benign etiologies, the most common infections that
result in thoracic lymphadenopathy are TB and fungal disease
(primarily histoplasmosis and coccidioidomycosis). Sarcoidosis is a
particularly frequent cause of this condition in young adults. Other
causes include silicosis, drug reactions, amyloidosis, heart failure,
Castleman's disease, and chronic obstructive pulmonary disease
(COPD) [7]. The aim of this review is to describe the patterns of
mediastinal and hilar lymphadenopathy found in benign diseases
in immunocompetent patients.1.1. Lymph node measurement and criteria for lymph node
enlargement
For the diagnosis of pathologically enlarged nodes, information
about normal node size is required. Commonly used metrics for
lymph node measurement include the maximum and minimum
axial diameters, and the ratio of these two values [8]. The shortest
axial diameter appears to be a more useful parameter than the
greatest axial diameter, although a different threshold should be
used for each nodal station [5,8,9].
The generally accepted size criterion for mediastinal lymph
node enlargement (>10 mm along the short axis) has been applied
to all patients when staging lymphoma or bronchogenic carcinoma
[10]. Other authors use the following standard maximum normal
short-axial diameters for nodal regions: region 7, 12 mm; regions 4
and 10R, 10 mm; and other regions, 8 mm. Maximum greatest axial
diameters show wider variation, ranging from 10 to 25 mm [9].
Lymph node location and age must also be taken into account
when evaluating lymph nodes in the pediatric chest. At least one
enlarged lymph node was found in 96% of children, with subcarinal
(69%), lower paratracheal (64%), and hilar (60%) nodes being most
common. Up to 10 years of age, most lymph nodes are 7 mm in
diameter. In older children, lymph nodes with short-axis diameters
of up to 10 mm have been found [11].1.2. Tuberculosis
TB is an airborne infectious disease caused by Mycobacterium
tuberculosis. It can be divided into primary and postprimary TB,
based on the absence or presence of prior infection and acquired
specific immunity, although the radiological appearances of these
manifestations overlap considerably [12].
Primary TB is most commonly seen in children. The initial focus
of infection ethe Ghon focus etends to be in the middle and lower
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although any lobe can be affected [12]. During the early stage of
infection, mycobacteria are commonly spread to regional lymph
nodes and via the bloodstream to other regions of the body. The
term utilized to refer the Ghon focus plus affected lymph nodes is
the “Ghon complex”. Although this complex may enlarge as the
disease progresses, it commonly undergoes a healing process,
resulting in a visible parenchymal scar (whichmay be calcified) and
enlarged or calcified nodes in the hilus or mediastinum [13,14].
Lymphadenopathy is the main feature of primary TB. It is
observed in 40% of adult cases and 90e95% of pediatric cases [14].
Unilateral compromise is usually present, and hilar lymph nodes
are most often affected. On CT, the most suggestive aspect of pri-
mary TB consists of enlarged lymph nodes egenerally >2 cm in
diametere with hypodense centers secondary to caseous necrosis,
as well as a peripheral denser area that increases after the
administration of contrast, representing a rim of granulomatous
inflammatory tissue (Fig. 1) [6].
Postprimary TB is a progressive condition that is rarely associ-
ated with lymphadenopathy. It usually presents as parenchymal,
airway, and pleural involvement. Hilar and mediastinal lymph-
adenopathy occur in only approximately 5% of immunocompetent
patients [12].
1.3. Fungal infections
Fungal infections, most notably histoplasmosis and pulmonary
coccidioidomycosis, can cause lymph node enlargement. The
former is a systemic infection that results from the inhalation of
airborne spores of Histoplasma capsulatum. In the acute form of this
disease, lymphadenopathy is a common finding (Fig. 2) and calci-
fications may be seen (Fig. 3) [15]. In the chronic form, however,
this finding is unusual, and the radiological manifestations are very
similar to those of postprimary pulmonary TB.
Direct infection of lymph nodes by H. capsulatum may lead to
the development of mediastinal granuloma ea mediastinal mass
made up of enlarged, caseous lymph nodes, sometimes partly liq-
uefied and surrounded by a thin fibrous capsule. Some authors
believe that this granuloma can lead to fibrosing mediastinitis,
presenting as a proliferation of fibrous tissue within the medias-
tinum and, in some instances, within the lumina of mediastinal
vessels and airways [16,17]. Thus, these authors argue that medi-
astinal granulomas should be resected when discovered, even in
the absence of presenting symptoms.
Coccidioidomycosis is a systemic mycosis caused by inhalation
of arthrospores of Coccidioides species. It can be divided into acute,Fig. 1. CT images from a 53-year-old man presenting with cough and fever, demonstrating
tuberculosis.disseminated, and chronic forms, each with a spectrum of imaging
findings [18]. CT shows hilar or mediastinal lymphadenopathy
associated with parenchymal abnormalities in 40% of patients with
the acute form of this disease [19]. Mediastinal lymphadenopathy
may persist after parenchymal abnormalities resolve; in such cases,
it has been proposed as a risk factor for disseminated infection
[20,21]. Nevertheless, consensus on this issue is lacking [22]. In
disseminated coccidioidomycosis, hilar and mediastinal lymph-
adenopathy is usually present, in association with miliary nodules
and confluent parenchymal opacities. Imaging manifestations of
the chronic form of the disease include residual nodules, chronic
cavities, pleural effusion, and persistent pneumonia with or
without lymphadenopathy [18].
1.4. Sarcoidosis
Sarcoidosis is a systemic granulomatous disease that affects
primarily the lung and lymphatic system. Five radiological stages of
intrathoracic changes have been defined: stage 0, no visible intra-
thoracic finding; stage 1, lymphadenopathy only; stage 2, lymph-
adenopathy with parenchymal infiltration; stage 3, parenchymal
disease only; and stage 4, pulmonary fibrosis [23].
Lymphadenopathy is seen in stages 1 and 2. The most common
pattern is bilateral hilar and right paratracheal lymphadenopathy,
also known as Garland's triad. The left paratracheal nodes and the
aortopulmonary window nodes are also commonly enlarged [24].
In general, when multiple lymph node groups in the hila and
mediastinum are symmetrically enlarged in a young patient,
sarcoidosis is the most likely diagnosis (Fig. 4). Amorphous, punc-
tate, or eggshell-like calcifications may also be seen and are sug-
gestive of a chronic condition, occurring in 3% of patients after 5
years and in 20% after 10 years [25].
Symmetry of hilar lymphadenopathy is an important feature
differentiating sarcoidosis from alternative diagnoses, such as
lymphoma, fungal disease, and TB [24]. Unilateral hilar adenopathy
occurs in only 3e5% of sarcoidosis cases and is the most common
atypical manifestation of the disease in patients aged >50 years
[26]. Mediastinal lymphadenopathy without hilar lymphadenopa-
thy is an unusual finding [24]. The involvement of the anterior or
posterior mediastinal lymph nodes is also infrequent and should
call into question the diagnosis of sarcoidosis [27].
1.5. Silicosis
Silicosis is caused by the inhalation of free silica particles during
occupational exposure esuch as in mining, drilling, andleft hilar hypodense lymphadenomegaly and leading to the diagnosis of lymph node
Fig. 2. CT images from a 36-year-old man presenting with cough, fever, and weight loss. (A,B) The images reveal subcarinal lymphadenomegaly and cavitated lesions on the upper
right lobe. (C) CT with coronal reconstruction demonstrated tree-in-bud centrolobular nodular disease in the right lung and left upper lobe. A biopsy of this node revealed
tuberculosis.
Fig. 3. CT images from a 55-year-old woman presenting with chronic cough, fever, and weight loss. Axial reconstruction of images obtained in the aortopulmonary window shows
calcified lymph nodes with diameters >1.2 cm(A), best demonstrated on maximum-intensity projection(B). A lymph node biopsy revealed histoplasmosis.
C.S. Nin et al. / Respiratory Medicine 112 (2016) 10e17 13sandblasting ewhich leads to a fibrous tissue reaction in the lungs
[28]. The classical features of patients with silicosis are diffuse
interstitial shadowing with bilateral enlargement of hilar lymph
nodes, which may or may not be calcified [29]. Antao et al. [30] also
found that 74% of silicotic patients had enlarged mediastinal lymph
nodes and 66% of exposed workers had evidence of lymph node
calcification. Eggshell calcification is the most common pattern
described in silicosis (Fig. 5) [28,31,32], although some authors have
reported that the puncate pattern is most prevalent [30,33].
Hilar andmediastinal lymphadenopathy have been suggested to
precede lung parenchymal silicosis [28,34,35]. Cox-Grasner et al.[36] found that 90% of subjects with parenchymal silicosis had
accompanying fibrotic lymph nodes. These findings support the
hypothesis that lymph node fibrosis impairs the elimination of
silica dust from the lungs, increasing the lung dust burden and
reflecting an additional risk for parenchymal silicosis.1.6. Amyloidosis
Amyloidosis is characterized by the accumulation of inappro-
priately folded protein deposits. It may be localized, but it is much
more commonly diffuse, affecting organ function by replacing the
Fig. 4. CT images from a 42-year-old woman presenting with chronic dyspnea. Axial (A) and coronal (B) reconstructions reveal pathologically enlarged mediastinal and hilar lymph
nodes. A lymph node biopsy revealed sarcoidosis.
C.S. Nin et al. / Respiratory Medicine 112 (2016) 10e1714normal cell structure. Based on the structure of the fibrillar protein
eone of the deposit's componentseamyloidosis is classified into
several types, most commonly primary and secondary [37].
Hilar and mediastinal lymph node enlargement is not described
in secondary amyloidosis, and is uncommon in localized amyloid-
osis. However, it is quite common in primary amyloidosis. Thoracic
lymphadenopathy, alone or with interstitial disease, is the most
common CT finding in primary amyloidosis. Mediastinal and hilar
lymph nodes may be involved, bilaterally and often massively,
resulting in a pattern that may resemble sarcoidosis. Calcification is
usually described as coarse or nonspecific, and eggshell calcifica-
tion may be seen. Associations with nephrotic syndrome, conges-
tive heart failure, and neuropathy can help identify the disease [7].1.7. Berylliosis
Berylliosis is a lung disease caused by the inhalation of beryl-
lium (Be) compounds. It can lead to acute chemical pneumonitis e
due to intense exposure to Be within a short time e or chronic
interstitial lung disease, after prolonged exposure to lower Be
concentrations. The chronic form is more common and presents asFig. 5. Images from a 62-year-old male coal worker presenting with chronic cough and dy
coronal CT reconstruction (A) and 3D volume rendering (B). An open lung biopsy confirmeintraalveolar accumulation of lymphocytes and macrophages,
alveolitis, and noncaseating granulomas [38].
CT appearances of chronic Be disease are similar to those of
sarcoidosis, although mediastinal and hilar lymphadenopathy are
less common, occurring in about 25% of patients. Be disease should
be included in the differential diagnosis for all patients with im-
aging appearances suggestive of sarcoidosis [39].1.8. Castleman's disease
Castleman's disease is an uncommon, mainly benign, lympho-
proliferative disorder of unknown etiology. The overall prevalence
of the disease is estimated to be less than 1/100,000 [40]. Castle-
man's disease may be localized or multifocal. The former presents
few or no symptoms, so its diagnosis is made typically through
incidental radiological findings. On chest radiographs, it may
appear as an incidental, rounded, solitary mediastinal or hilar mass
with a differential diagnosis that includes thymoma, lymphoma,
neurogenic tumor, and bronchial adenoma [41]. On CT, it usually
manifests as a homogeneous, noninvasive, large, solitary mass with
soft-tissue attenuation (Fig. 6), most commonly in themediastinumspnea. Note the extensive eggshell-like lymph node appearance at all stations on the
d the diagnosis of silicosis.
Fig. 6. Images from a 42-year-old man with acute viral infection whose x-ray showed widening of the mediastinum. (A, B) CT confirmed lymph node enlargement, especially in the
subcarinal region. (C) Positron emission tomography shows increased 18F-FDG uptake. A biopsy of this node revealed Castleman's disease.
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Other patterns that may be seen in the localized form of this
disease are a dominant mass with involvement of contiguous
structures and, less frequently, matted lymphadenopathy confined
to a single mediastinal compartment [41]. Hypervascularity of the
lesion may lead to homogeneously intense enhancement following
administration of contrast. Intralesional calcifications are uncom-
mon (occurring in 5e10% of cases); when present, they are typically
coarse and central [41,42].
Multifocal Castleman's disease presents with inflammatory
symptoms including fever, night sweats, weight loss, and anemia.
Currently, it is most commonly diagnosed in individuals infected
with HIV-1, although it certainly can develop in immunocompetent
individuals [43e45]. Multifocal Castleman's disease manifests itself
with generalized lymphadenopathy [46]. In patients with multi-
focal disease, thoracic imaging may show bilateral hilar and
mediastinal enlargement of lymph nodes (1e3-cm diameters), as
well as diffuse reticulonodular pulmonary infiltrations [41,47].
However, radiological findings are not sufficiently reliable to
establish a diagnosis of Castleman's disease, which requires histo-
logical confirmation [46].1.9. Viral infections
Several viruses, including EpsteineBarr virus (EBV), varicella-
zoster virus, hantaviruses, influenza viruses, and dengue virus,
can cause lower respiratory tract infection in immunocompetent
adults. Radiological manifestations of viral infections include small
ill-defined nodules, ground-glass opacities, and areas of consoli-
dation. Thoracic lymphadenopathymay also be found, although it is
not common [48].
Among these viruses, lymphadenopathy is among the main
features of EBV. Infectious mononucleosis ecaused by primary
infection by this viruse manifests with the typical triad of fever,
pharyngitis, and lymphadenopathy, often accompanied by
splenomegaly [49]. Despite its importance, however, reports of
hilar lymphadenopathy associated with EBV have been confined
largely to the radiological literature [50].
Varicella-zoster virus infection manifests primarily as chick-
enpox or herpes zoster, and is more commonly seen in children
[49]. The disease can evolve to pneumonia, more commonly in
pregnant and immunosuppressed patients [51,52]. Imaging of the
chest in varicella pneumonia usually shows diffuse nodules,
sometimes coalescent, with a surrounding halo of continuous or
patchy ground-glass opacity. Although uncommon, lymphade-
nopathy may be seen [53]. Maher et al. [54] found mediastinallymphadenopathy in a patient with this type of pneumonia after
lung transplantation. Hilar lymphadenopathy ewhich subsided as
the pulmonary infection resolved ehas also been reported [55].
The genus Hantavirus chronically infects rodents without
apparent disease; when spread to humans, it can lead to hemor-
rhagic fever with renal syndrome (HFRS) and hantavirus pulmo-
nary syndrome (HPS), both accompanied by myocardial depression
and hypotension or shock [56]. Reports of thoracic lymphadenop-
athy in hantavirus infections are scarce. A study performed with
patients infected by the hantavirus Puumala virus e which causes
HFRS e showed hilar and mediastinal lymphadenopathy in only a
minority of cases [57]. The authors suggested that lymphadenop-
athy was related to capillary leakage and overall fluid overload, as
these patients also presented with pleural effusion and pericardial
fluid. In addition, Rovida et al. [58] reported a case of HPS pre-
senting diffuse nodular infiltrates associated with
lymphadenopathy.
Thoracic lymph node abnormalities are not commonly found in
immunocompetent patients with influenza virus infections. Ver-
rastro et al. [59] described the spectrum of CT findings in nine
patients with laboratory-confirmed influenza A infection. Medias-
tinal lymphadenopathy was found in two of the subjects. In a
similar study, lymphadenopathy was found in two of three sub-
jects. The nodes enhanced homogeneously, measured 1 cm along
the short axis, and involved the right hilar, carinal, and subcarinal
nodal stations [60].
The clinical spectrum of dengue virus infection ranges from
asymptomatic to severe illness [61]. Physical examination often
reveals generalized lymphadenopathy, as efollowing a bite by an
infected mosquitoe the virus replicates in the regional lymph
nodes and is disseminated via the lymph and blood to other tissues
[62e64].
Although most viral infections in immunocompetent persons
are self-limited, some patients can develop pneumonia (when
parenchymal involvement occurs). In such cases, follow-up chest
imaging after diagnosis is important to ensure that a pulmonary
malignancy is not missed [65].1.10. Heart failure
Chronic left heart failure may cause mediastinal lymphade-
nopathy. Several mediastinal lymphatic chains are involved, but the
subcarinal, paratracheal, and hilar nodes are more frequently
affected. The mechanisms underlying the pathogenesis of lymph-
adenopathy in cardiogenic pulmonary edema are not completely
clear, but it has been suggested to be the expression of diffuse
Table 1
Main features of benign lymphadenopathy.
High density Asymmetrical Bilateral Calcification
Sarcoidosis x x
Silicosis x x
Amyloidosis x x
Berylliosis x x
Tuberculosis x x
Castleman's disease x
Normal Density
Heart failure
Pulmonary fibrosis
COPD
Drug-induced lymphadenopathy x
Pulmonary embolism
Viral infection x
Low Density
Tuberculosis x x
Fungal infection x x
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neighboring structures, including the mediastinum and associated
lymph nodes [66]. Lymphadenopathy has been suspected based on
features observed on radiographs taken to investigate dyspnea and
heart failure. The identification of suspicious features is theoreti-
cally easier on follow-up radiographic examinations, which provide
better visibility of hilar and mediastinal areas, after treatment to
reduce pulmonary edema [66].
1.11. Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic
fibrosing interstitial pneumonia limited to the lung [67]. The re-
ported prevalence of mediastinal lymphadenopathy in IPF is 66%
(90/136 patients) [68] or, similarly, 70% [69]. The presence of
enlarged mediastinal nodes may indicate a more chronic and
advanced disease process [70]. Jung et al. [71] showed that the total
number of enlarged lymph nodes increased with the severity score
of pulmonary fibrosis.
IPF was reported to be associated with an increased risk of lung
cancer, due to the occurrence of atypical or dysplastic epithelial
changes in fibrosis, which progress to invasive malignancy [72].
Consensus on this association is lacking, but epidemiological re-
ports have described an increased incidence of lung cancer during
IPF follow-up. In addition, lung cancer was found simultaneously
with IPF in some autopsy studies [73]. The relation between the IPF
severity score ofe reflected in the number of enlarged lymph nodes
e and the emergence of lung cancer also remains uncertain and
offers a potential area for further investigation [67,72].
1.12. Chronic obstructive pulmonary disease
COPD is characterized by progressive airflow obstruction,
inflammation in the airways, and systemic effects or comorbidities
[74]. Approximately 50% of patients with COPD present enlarged
hilar and mediastinal lymph nodes. These lymph nodes are located
predominantly in the lower paratracheal space, in the aorto-
pulmonary window, and below the carina. Lymph node enlarge-
ment is identified more often in patients with signs of severe
bronchitis, which seems to be logical because the inflammatory
processes seen in chronic bronchitis may result in airway remod-
eling and narrowing and reactive nodal enlargement. All enlarged
lymph nodes in patients with COPD have well-defined contours,
and most are oval. Neither calcification nor central low attenuation
of enlarged lymph nodes is seen in the majority of patients [75].
1.13. Pulmonary embolism
Lymphadenopathy is common in patients with pulmonary
arterial hypertension caused by proven chronic pulmonary
thromboembolism, and may not necessarily implicate additional
pulmonary disease. Enlarged nodes are found on CT in more than
one-third of patients with chronic pulmonary thromboembolism
with no clinical or radiological evidence of comorbid conditions.
The frequent association between enlarged hilar lymph nodes and
pleural and pericardial effusions raises the possibility of a common
pathophysiological mechanism related to the slowing of lymphatic
flow in the mediastinum, caused by increased pressure in the
systemic venous system [76].
1.14. Drug-induced lymphadenopathy
Hypersensitivity reactions to drugs can cause mediastinal or
hilar lymph node enlargement. Anticonvulsants, particularly
phenytoin, can cause a pseudolymphoma syndrome withgeneralized lymphadenopathy in addition to fever, skin rash,
eosinophilia, and hepatosplenomegaly. Methotrexate, sulfon-
amides, penicillin, allopurinol, aspirin, and erythromycin are other
examples of drugs with this effect. These reactions tend to follow
several months of drug therapy and decrease after discontinuation
of the drug [7].
The main characteristics of the previously described lymph-
adenopathies are summarized in Table 1.
2. Conclusion
Patterns of thoracic lymphadenopathy can provide important
clues to the diagnosis of many benign diseases. Careful evaluation
of these findings is important to decrease the number of unnec-
essary interventions. Knowledge of the limitations of size and site
criteria in predicting nodal status is important to correctly indicate
the need for follow-up imaging or pathological confirmation.
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